📰 Thomas Triomphe News
Page 2 - Thomas Triomphe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Triomphe. Real-time updates on events, politics, business and more.
August 4, 2023
Bsip/Universal Images Group via Getty Images(WASHINGTON) -- A new immunization to protect infants from respiratory syncytial virus, or RSV was approved by the Centers for Disease Control and Prevention on Thursday. The approved drug called nirsevimab, which will be marketed in the U.S. by Sanofi as Beyfortus, was recommended unanimously by the CDCs Advisory Committee on Immunization Practice for all children under 8 months old and signed off on by CDC director Dr. Mandy Cohen, the last step in t...
August 4, 2023
A federal advisory panel recommended the new shot to be given to babies during or entering their first RSV season, similar to how a vaccine works.
August 4, 2023
Bsip/Universal Images Group via Getty Images(WASHINGTON) -- A new immunization to protect infants from respiratory syncytial virus, or RSV was approved by the
August 4, 2023
All infants under 8 months of age should get a new antibody shot to protect against RSV, according to a recommendation from the CDC.
August 4, 2023
All infants under 8 months of age should get a new antibody shot to protect against RSV, according to a recommendation from the CDC.
August 4, 2023
All infants under 8 months of age should get a new antibody shot to protect against RSV, according to a recommendation from the CDC.
August 4, 2023
All infants under 8 months of age should get a new antibody shot to protect against RSV, according to a recommendation from the CDC.
August 4, 2023
(CNN) — All infants under 8 months of age should get a new antibody shot to protect against severe respiratory syncytial virus, or RSV, according a recommendation from the US
August 3, 2023
The expert advisory board dealing with immunizations for the Centers for Disease Control and Prevention (CDC) voted unanimously Thursday to recommend a new treatment for preventing RSV in infants and toddlers. The voting members of the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously voted yes to recommending that the RSV monoclonal antibody treatment Nirsevimab…